In the six months since President Trump’s inauguration, U.S. Customs and Border Protection has received hundreds of news media Freedom of Information Act requests seeking information about the Trump ...

Hyatt Hotels announced plans to sell its Playas real estate portfolio, just acquired from Playa as recently as June 17, 2025, for $2 billion to Tortuga Resorts, a joint venture between an affiliate of ...

The world’s largest home improvement retailer, Home Depot, announced plans to acquire GMS, a leading North American specialty building products distributor, for $5.5 billion. The all-cash deal is ...

ExodusPoint burst onto the hedge fund scene in 2018 with the largest launch in history — raising $8.5 billion out of the gate — powered by institutional backing, an elite Wall Street pedigree, and ...

Amid President Trump’s recent high-profile efforts to punish or extract concessions from major law firms, a second front, much less publicized, has opened, with organizers of Project 2025 using ...

As malls across America struggle for shoppers, DICK’S Sporting Goods, Inc. announced plans to acquire Foot Locker, Inc. for $2.5 billion. The merger agreement permits Foot Locker shareholders to ...

We’re taking a look this week at a frequently used Freedom of Information Act exemption that isn’t mentioned anywhere in the statutory language. It’s known as “Glomar” among the federal ...

Citing New Evidence, Surviving Family Members Sue Feds, Raytheon and Lockheed Martin Over 1996 TWA Crash ...

Artificial Intelligence (AI), is a decades-old field in computer science. Brad Myers, director of the Human-Computer Interaction Institute at Carnegie Mellon University, defines it as “a broad ...

Carson Block is a buccaneering stock trader, reveling in a role that’s long on risk and short on sympathy. He’s an activist short seller, the most reviled guy in any room full of corporate ...

The Democratic National Committee’s latest Freedom of Information Act requests reveal an expanded effort to dig up details about possible federal investigations into various companies associated ...

Novartis announced plans to acquire Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company developing medicines targeting microRNAs, for $800 million. The all cash deal includes a ...